These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26822708)
1. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. Ilangumaran S; Villalobos-Hernandez A; Bobbala D; Ramanathan S Cytokine; 2016 Jun; 82():125-39. PubMed ID: 26822708 [TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor in physiology and infectious diseases. Imamura R; Matsumoto K Cytokine; 2017 Oct; 98():97-106. PubMed ID: 28094206 [TBL] [Abstract][Full Text] [Related]
3. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis. Moransard M; Sawitzky M; Fontana A; Suter T Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340 [TBL] [Abstract][Full Text] [Related]
4. The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Skibinski G; Skibinska A; James K Immunology; 2001 Apr; 102(4):506-14. PubMed ID: 11328385 [TBL] [Abstract][Full Text] [Related]
5. The HGF receptor/Met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity. Baek JH; Birchmeier C; Zenke M; Hieronymus T J Immunol; 2012 Aug; 189(4):1699-707. PubMed ID: 22802413 [TBL] [Abstract][Full Text] [Related]
6. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. Chen PM; Liu KJ; Hsu PJ; Wei CF; Bai CH; Ho LJ; Sytwu HK; Yen BL J Leukoc Biol; 2014 Aug; 96(2):295-303. PubMed ID: 24714552 [TBL] [Abstract][Full Text] [Related]
7. The Impact of the Epithelial-Mesenchymal Transition Regulator Hepatocyte Growth Factor Receptor/Met on Skin Immunity by Modulating Langerhans Cell Migration. Sagi Z; Hieronymus T Front Immunol; 2018; 9():517. PubMed ID: 29616031 [TBL] [Abstract][Full Text] [Related]
8. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Chen Q; DeFrances MC; Zarnegar R Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release. Komarowska I; Coe D; Wang G; Haas R; Mauro C; Kishore M; Cooper D; Nadkarni S; Fu H; Steinbruchel DA; Pitzalis C; Anderson G; Bucy P; Lombardi G; Breckenridge R; Marelli-Berg FM Immunity; 2015 Jun; 42(6):1087-99. PubMed ID: 26070483 [TBL] [Abstract][Full Text] [Related]
17. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631 [TBL] [Abstract][Full Text] [Related]
18. HGF/c-MET targeted therapeutics: novel strategies for cancer medicine. Yap TA; Sandhu SK; Alam SM; de Bono JS Curr Drug Targets; 2011 Dec; 12(14):2045-58. PubMed ID: 21777195 [TBL] [Abstract][Full Text] [Related]
19. The role of hepatocyte growth factor/c-met interactions in the immune system. Skibinski G Arch Immunol Ther Exp (Warsz); 2003; 51(5):277-82. PubMed ID: 14626426 [TBL] [Abstract][Full Text] [Related]
20. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment. Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]